Defiance ETFs’s Astera Labs ALAB Stock Holding History

Defiance ETFs’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$91.7M	Sell	212,915 -52,524	-20%	-$13.9M	1.25%	12
2026 Q1	$29.1M	Buy	265,439 +22,372	+9%	+$3.19M	0.42%	73
2025 Q4	$41.5M	Buy	+243,067	New	+$40.7M	1.36%	13

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Defiance ETFs's ALAB Position: Q2 2026 in Review

Defiance ETFs reduced its Astera Labs (ALAB) stake by 20% in Q2 2026, selling an estimated $13.9M and leaving 212,915 shares worth $91.7M. The position accounts for 1.25% of the portfolio, ranked #12.

Defiance ETFs first reported a position in ALAB in Q4 2025 and has held it in 3 quarters since. 985 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

Defiance ETFs held 212,915 shares of Astera Labs worth $91.7M as of Q2 2026.
Defiance ETFs sold 52,524 Astera Labs shares in Q2 2026, an estimated $13.9M.
Astera Labs made up 1.25% of Defiance ETFs's portfolio in Q2 2026, its #12 holding.
Defiance ETFs first reported a position in Astera Labs in Q4 2025 and has held it in 3 quarters since.
985 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Defiance ETFs's 13F filing for Q2 2026, filed 14 Aug 2026.